DAMORA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
DAMORA THERAPEUTICS, INC. (DMRA) had Shares Outstanding (Cover Page) of 61.74 million shares as of 2026-08-07, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-07: Entity Common Stock, Shares Outstanding 61.74M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 61.55M shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 60.30M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 1.33M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 61.74M shares 10-Q · filed 2026-08-10 |
| 2026-05-11 | 61.55M shares 10-Q · filed 2026-05-12 |
| 2026-03-17 | 60.30M shares 10-K · filed 2026-03-19 |
| 2025-11-03 | 1.33M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 1.32M shares 10-Q · filed 2025-08-05 |
| 2025-05-05 | 1.32M shares 10-Q · filed 2025-05-08 |
| 2025-03-14 | 1.32M shares 10-K · filed 2025-03-19 |
| 2024-10-30 | 1.32M shares 10-Q · filed 2024-11-01 |
| 2024-08-07 | 27.13M shares 10-Q · filed 2024-08-12 |
| 2024-04-24 | 27.11M shares 10-Q · filed 2024-04-29 |
| 2024-03-05 | 27.11M shares 10-K · filed 2024-03-08 |
| 2023-11-01 | 27.11M shares 10-Q · filed 2023-11-06 |
| 2023-07-26 | 27.11M shares 10-Q · filed 2023-07-31 |
| 2023-04-26 | 25.67M shares 10-Q · filed 2023-04-28 |
| 2023-03-06 | 25.67M shares 10-K · filed 2023-03-09 |
| 2022-11-04 | 25.58M shares 10-Q · filed 2022-11-08 |
| 2022-07-27 | 25.40M shares 10-Q · filed 2022-07-29 |
| 2022-04-27 | 25.26M shares 10-Q · filed 2022-04-29 |
| 2022-02-15 | 25.26M shares 10-K · filed 2022-02-17 |
| 2021-11-02 | 25.26M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 25.26M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 25.26M shares 10-Q · filed 2021-05-04 |
| 2021-03-25 | 25.26M shares 10-K · filed 2021-03-29 |
| 2020-12-10 | 25.26M shares 10-Q · filed 2020-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |